Success Predictors of Adjuvant Chemotherapy in Node-Negative Breast Cancer Patients Under 55 years1
Background: Adjuvant systemic chemotherapy (ASCT) in lymph node-negative breast (LN−) cancers improves survival. The majority of (LN−) patients receive ASCT when the St. Gallen criteria or its modifications are used, as accurate identifiers which patients benefit from ASCT are lacking. This may impl...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2006-01-01
|
| Edice: | Cellular Oncology |
| On-line přístup: | http://dx.doi.org/10.1155/2006/152341 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|